ProShare Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

ProShare Advisors’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,602	Closed	-$725K	–	1893
2023 Q2	$725K	Buy	15,602 +8,131	+109%	+$281K	﹤0.01%	804
2023 Q1	$214K	Sell	7,471 -1,027	-12%	-$30.4K	﹤0.01%	1411
2022 Q4	$265K	Buy	+8,498	New	+$277K	﹤0.01%	1310

ProShare Advisors's DICE Position: Q3 2023 in Review

ProShare Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 15,602 shares — an estimated $725K sold.

ProShare Advisors first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $725K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

ProShare Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
ProShare Advisors sold 15,602 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $725K.
ProShare Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
ProShare Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $725K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on ProShare Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.